Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:1206161-97-8,CAS 1206161-97-8,CAS NO 1206161-97-8
Conbott Pharmtech Co.,Ltd. 1206161-97-8,CAS 1206161-97-8,CAS NO 1206161-97-8
Home > Products > Inhibitors > JAK Inhibitors > Selective JAK1 Inhibitor Filgotinib (GLPG0634) CAS 1206161-97-8
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Selective JAK1 Inhibitor Filgotinib (GLPG0634) CAS 1206161-97-8

Share to:  
    Payment Type: T/T,L/C
    Min. Order: 1 Gram

Basic Info

Model No.1206161-97-8

BrandConbottpharm

Additional Info

PackagingAs required

ProductivityCustomized

TransportationOcean,Air

Place of OriginChina

Supply AbilityCommercial

CertificateDocuments Support

Payment TypeT/T,L/C

Product Description


We are well known in the market for offering Filgotinib CAS 1206161-97-8, also known as GLPG0634. Filgotinib (GLPG0634) CAS NO 1206161-97-8 is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively. In cell lines, GLPG0634 shows higher selectivity for JAK/STAT signaling involving JAK1 than JAK2 kinase in a cellular context. Processed Filgotinib (GLPG0634) 1206161-97-8 use superior quality raw material and in a clean and sterile condition. We promise the Filgotinib (GLPG0634) Cas 1206161-97-8 is high specification and high purity.


Thera. Category: JAK Inhibitor

Cas No.: 1206161-97-8

Synonym: GPLG0634;GLPG0634;SYN1158;CyclopropanecarboxaMide, N-[5-[4-[(1,1-dioxido-4-thioMorpholinyl)Methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-;GLPG0634 (analog);N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide;Filgotinib (GLPG0634);N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide Filgotinib (GLPG0634)

1206161-97-8

Molecular Formula: C21H23N5O3S

Molecular Weight:425.51

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Filgotinib (GLPG0634) is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively. Phase 2.

Related Product:
CAS 1206161-97-8, Filgotinib (GLPG0634)
CAS 59801-62-6, THIOMORPHOLINE 1,1-DIOXIDE HYDROCHLORIDE
CAS 1142943-96-1, Cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide

Product Categories : Inhibitors > JAK Inhibitors

Product Images
  • Selective JAK1 Inhibitor Filgotinib (GLPG0634) CAS 1206161-97-8
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2024 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?